Financials
- Market Capitalization 241.58 M
- Employee 122
- Founded 2020
- CEO N/A
- Website www.invivyd.com
- Headquarter Delaware, United States
- FIGI BBG00W4ML039
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.48
ratio cours/chiffre d'affaires
4.07
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3518 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.57 USD | -0.56% | -4.29% | +1.13% | -54.70% | 237.88 M USD | ||
| 3528 | TARA Protara Therapeutics, Inc. - Common Stock | 4.12 USD | +0.73% | +0.24% | +4.30% | +33.77% | 231.56 M USD | ||
| 3552 | DTIL Precision BioSciences, Inc. - Common Stock | 8.79 USD | +2.45% | -5.28% | +41.55% | +102.07% | 226.80 M USD | ||
| 3556 | AVXL Anavex Life Sciences Corp. - Common Stock | 2.50 USD | +2.88% | -7.41% | +0.40% | -77.15% | 231.68 M USD |